NuVasive Announces $30M Unfavorable Jury Verdict for Use of Trade-Name 'NeuroVision' 8-K

By: via Benzinga
On April 3, 2014, an unfavorable jury verdict was delivered against NuVasive (NASDAQ: NUVA), relating to NuVasive's use of the trade ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.